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Abstract  
BACKGROUND: Neurofibromatosis type 1 is an autosomal dominant condition that has a variety of 
clinical manifestations. Essential or secondary hypertension may be associated with 
neurofibromatosis. A rare finding is hypertension due to pheochromocytoma in patient with 
neurofibromatosis type 1.  
CASE REPORT: We present a case with a 7-year medical history of hypertension which was 
poorly controlled and with wide variations of blood pressure before the examination. Investigations 
did not reveal a secondary cause of hypertension. After the physical examination and establishing 
the diagnosis of neurofibromatosis, as well as the history of symptomes suggestive of 
catecholamine discharge, diagnostic procedures for pheochromocytoma were undertaken. 
Abdominal CT and MRI have proven the presence of a right adrenal tumor mass which was 
suspected to be a pheochromocytoma. Patient was preoperatively treated for two weeks with alpha 
and beta blokers and right adrenalectomy was performed. Perioperatively and on a longer term, 
blood pressure remained well controlled with less antihypertensive therapy. Diagnosis and 
management of pheochromocytoma in neurofibromatosis involves a dermatologist, endocrinologist, 
nephrologist and an urologist and requires a well-coordinated multidisciplinary approach.  
CONCLUSIONS: Pheochromocytoma, although a rare condition in patients with neurofibromatosis, 
may be a cause for uncontrolled hypertension, as well as other cardiovascular complications and 
the clinician should do all available clinical investigations to confirm it or exclude it on time.  
 
 
 
 
 
 
Introduction 
 
Neurofibromatosis (NF) is a genetic disorder 
that involves multiple systems, and is known as 
neurocutaneous syndrome. Neurofibromatosis type 1 
(NF1), also known as von Recklinghausen disease is 
an autosomal dominant condition [1]. The 
manifestations of NF1 result from a mutation in or 
deletion of the NF1gene with location at 17q11.2 [2]. 
The gene serves as tumour suppressor via its product 
called neurofibromin [3].  
Neurofibromatosis type 1 may present with 
various cutaneous manifestations (cafe au lait 
patches, freckling on skin folds), iris Lisch nodules 
and neurofibromas. Less frequently it may involve 
central nervous tumors, malignant peripheral nerve 
sheath tumors, neurological,cognitive problems and 
ortopedic and gastrointestinal problems [4].  
Pheochromocytoma occurs in 0.1%-5.7% of 
patients with NF-1. The incidence increases up to 
20% among patients with hypertension [5]. Although 
rare, it may be the cause of uncontrolled hypertension 
as well as hypertension with wide variations. 
Diagnosis is a clinical one and high level of suspicion 
of the condition is needed to proceed with the clinical 
investigations.  
We present a case with pheochromocytoma 
and neurofibromatosis type 1 with hypertension, who 
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was successfully treated with unilateral laparoscopic 
adrenalectomy.  
 
 
Case description  
 
The patient G.N, born in 1979, was referred to 
the University clinic of nephrology for clinical 
assessment for secondary hypertension. He had his 
first high blood pressure measurement 7 years ago, 
with maximum values for blood pressure up to 
190/110 mmHg and presented with symptoms 
suggestive of catecholamine release. Investigations 
were started and therapy was given, but he had poor 
compliance due to blood pressure variability. He 
attended his general practicioner 2 monts before 
consulting to the clinic,and broad investigations for the 
etiology of the secondary hypertension were made.  
Although regular antihypertensive treatment 
was continued, he had an elevation of the blood 
pressure (BP) up to 170/90 mmHg with clinical picture 
suggestive for catecholamine release. Supportive 
findings for secondary hypertension were those from 
abdominal ultrasound, renal ultrasound, abdominal CT 
and MRI, biochemistry, echocardiography, 
dermatological and endocrinological examinations. 
Past medical history included hyperthyroidism 
diagnosed 2 years ago and treated for 6 months, with 
no current treatment needed. His father had diabetes 
mellitus and no other significant diseases in the family 
were present.  
 
Figure 1: Tumor mass in the right cervical area 
 
When the patient presented at the Clinic, his 
office blood pressure was 125/85 mmHg, and he was 
on treatment with a beta-blocker – Bisoprolol, an ACE 
inhibitor – Lisinopril, and Prazepam. A tumour mass 
was seen in the right cervical area and it was firm, 
limited and mobile, but the patient has done no further 
investigations for it (Fig. 1). Numerous discolorated 
patches were visible on the back, suggesting cafe-au-
lait spots (Fig. 2).  
 
Figure 2: Cafe-au-lait spots on the back 
 
Abdominal ultrasound showed a 
parenchymal, well-defined mass lesion size 51 x 53 
mm seen at the area superior to the right upper kidney 
pole and below the right liver lobe, and adrenal gland 
origin could not be ruled out. Both kidneys had normal 
structure and location. Left adrenal gland was normal 
and in right adrenal gland, an oval, non-homogeneous 
tumour mass with dimensions – 54 x 63 mm was 
seen. Prostate was enlarged and homogeneous with 
size 33 x 32 x 30 mm.  
 
Figure 3: Right suprarenal mass on abdominal ultrasound 
 
Abdominal CT showed a well-defined, oval, 
soft tissue lesion, largest diameter of 6 cm, which 
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suppresses the upper pole of the kidney seen in the 
right adrenal gland (Fig. 3). After application of 
contrast there was an intensive increment of 
attenuation with central hypoattenuation area of 
necrosis and increased attenuation persisted on the 
scan done 10 min later.  
 
Figure 4: Adrenal tumor on abdominal CT  
 
On MRI, cutaneous neurofibromas were seen 
over the left abdominal wall above the umbilicus. 
Liver, spleen, pancreas, left adrenal gland and both 
kidneys have normal morphology. In the right 
suprarenal area a well defined heterogeneous mass, 
size 6.0 x 5.5 cm, that suppress the upper pole of the 
right kidney was seen. MRI findings are consistent 
with Pheochromocytoma.  
Laboratory findings revealed hyperglycemia 
but all other parameters were within normal (Table 1). 
Several other investigations were performed, 
considering the working diagnosis od 
neurofibromatosis and its possible variety of 
manifestations and consequences. Echocardiogram 
was normal. Ophthalmological findings were 
unremarkable.Dermatological exam diagnosed the 
condition as Neurofibromatosis type 1. 
Endocrinological consultation was consistent with 
Neurofibromatosis type 1, Right adrenal tumor, and 
Pheochromocytoma suspected, and surgical 
treatment was recommended.  
Table 1: Laboratory findings of the patient at check-up at the 
Clinic 
Erythrocytes :   5.0  (4.2-5.5 x 10
12
 /l) 
Platelets :  352 (140-340 x 10
9
 /l) 
Leucocytes :  9.8 (4-9 x 10
9
 /l) 
Hb   152 (140-180  g/l ) 
Neutrophils   0.71 (0.58-0.66) 
Glucose :  6.5 (3.5-6.5 mmol/l) 
Na-  146 (137-145 mmol/l) 
K- 4.6 (3.8-5.5 mmol/l) 
Ca- 2.5 (2.1-2.6 mmol/l) 
Urea and creatinine –  within the  normal reference range 
 
 
Differential diagnosis includes metastatic 
lesions e.g. melanoma, pheochromocytoma (clinical 
and biochemical correlation is needed), adrenal 
carcinoma and neurofibroma.  
Final diagnosis were secondary hypertension, 
right adrenal tumour and neurofibromatosis type 1 and 
two weeks prior to surgery, therapy with Prazosin 4 
mg daily dose and in few days both Prazosin and 
Propranolol 120 mg daily dose were started.  
The patient was admitted at University clinic 
of Urology and underwent laparoscopic removal of the 
tumour mass of the adrenal gland. Tumour consisted 
of mature feohromocytes (Fig. 4), with polygonal 
appearance and abundant basophilic granular 
cytoplasm. Immunophenotyping was consistent with 
neuroendocrine tumour markers CHR A (+) NSE (+).  
 
Figure 5: Histological finding of the tumour - feochromocytes 
 
After surgery, blood pressure was within 
normal range, and antihypertensive treatment was 
corrected. Two weeks after surgery the patient was in 
good general condition, blood pressure was in the 
normal range and antihypertensive therapy was 
stopped. 
 
  
Discussion  
 
According to National Institutes of Health 
(NIH) Consensus Conference document developed in 
1987 [1], neurofibromatosis can be diagnosed if two or 
more criteria are fulfilled: six or more cafèau-lait spots, 
two or more neurofibromas of any type, freckling in 
the axillary or the inguinal regions, optic glioma, two or 
more Lisch nodules; a typical osseous lesion or a first 
degree relative affected by NF1.  
These diagnostic criteria are still valid and the 
diagnosis of patients with neurofibromatosis is a 
clinical one. Differential diagnosis should be made 
from other forms of neurofibromatosis, other 
conditions with cafe-au-lait patches and pigmented 
macules, overgrowth syndromes and other tumors 
confused with neurofibromatosis [4].  
Our patient fulfilled the clinical criteria for 
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diagnosis of neurofibromatosis type 1. Diagnosis of 
neurofibromatosis type 1 is often delayed and may 
attract medical attention when other symptoms and 
clinical problems arise. The condition is associated 
with vasculopathy which is 2.2 times more frequent in 
patients with neurofibromatosis aged 30–40-years. 
Vasculopathy may be associated to the protein 
neurofibromin, which is assocaited with lumen 
occlusion and hyperplasia of vessel intima. Often it is 
manifested with hypertension, which may be due to 
renal artery stenosis, coarctation of aorta, 
pheochromocytoma or may be essential [6].  
Association between neurofibromatosis and 
pheochromocytoma was reported by Suzuki in 1910 
[7]. It is an uncommon manifestation of 
neurofibromatosis and its incidence is reported as low. 
Yet, pheochromocytoma remains often, in up to 20% 
with neurofibromatosis type 1, undiagnosed when the 
level of clinical suspicion is low [8]. In 20-56% of 
patients with NF1 and hypertension, 
pheochromocytoma is diagnosed [9].  
Our patient had a 7-year history of 
hypertension and when the variability of the blood 
pressure despite the use of antihypertensives became 
significant, the patient started clinical investigations. 
Catecholamine discharge which occurs in 
pheochromocytoma is not only a cause for variability 
of blood pressure, but it may cause myocardial injury 
and arrythmias [9].  
The best diagnostic test for 
pheochromocytoma is serum metanephrine [10]. 
Computer tomography of the abdomen is the 
fundamental examination and MRI of the suprarenal 
glands has the highest sensitivity [11, 12]. 
Scintigraphy with MIBG is useful particularly when 
pheochromocytoma is not from adrenal origin. 
Unfortunately, the test for serum metanephrines is not 
available in our country. In our case, abdominal CT 
and MRI have correctly determined the location of the 
tumor.  
Treatment of choice is adrenalectomy, which 
was performed in our patient after two weeks of 
preparation with medications. Beta blockers should be 
used only after successful alpha blockade. Our patient 
had an adequate preoperative and perioperative 
treatment and the long-term control of blood pressure 
was satisfactory. Cases report that 
pheochromocytoma is often an incidentaloma, with no 
clinical manifestations [13] and different outcomes are 
described, from well-controlled hypertension to acute 
myocardial infarction [14, 15].  
Pheochromocytoma, although a rare condition 
in patients with neurofibromatosis, may be a cause for 
uncontrolled hypertension, as well as other 
cardiovascular complications and the clinician should 
do all available clinical investigations to confirm it or 
exclude it on time.  
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